Learn how CROs can leverage eClinical technology to more effectively differentiate themselves in the crowded marketplace and provide sponsors with better clinical trial support.
Recently, early-phase protocols have been collecting patient-reported outcomes (PROs) not only to get regulatory approval but to demonstrate value to public and private payers.
Discover how ePRO automatically incorporates eCOA data into a study, improving the depth, timeliness, and accuracy of patient-reported outcomes data in the following ways.
In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.
In this article, focus on the adoption of new clinical trial technology and explore how sponsors can support sites as they select and implement technologies.
The benefits of eConsent are multi-faceted. In this blog post, explore these advantages as they relate to participants, sites and sponsors/CROs.
When participant retention is not addressed, learn how studies need to recruit additional participants and extend trial timelines, leading ultimately to budget overruns.
eConsent can have a positive impact on participant retention, but learn why that is only part of the challenge of meeting participant needs in a clinical trial.
Get the latest articles from Clinical Leader delivered to your inbox.